Radiation-Associated Kidney Injury

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3 SUPPL., 2010, Pages

  Dawson, Laura A ^a   Kavanagh, Brian D ^b   Paulino, Arnold C ^c   Das, Shiva K ^d   Miften, Moyed ^b   Li, X Allen ^e   Pan, Charlie ^f   Ten Haken, Randall K ^f   Schultheiss, Timothy E ^g  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Kidney injury; Radiation toxicity; Radiotherapy

Indexed keywords

ANGIOTENSIN-CONVERTING ENZYME; ANIMAL MODEL; KIDNEY INJURY; NEPHROPATHY; PATHOPHYSIOLOGY; PREDICTIVE MODELS; RADIATION INJURY; RADIATION TOXICITY; TOTAL BODY IRRADIATION; TREATMENT GUIDELINES; VOLUME PARAMETERS;

RADIOTHERAPY; TOXICITY;

RADIATION;

ACETYLSALICYLIC ACID; CYCLOSPORIN; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUDARABINE; TENIPOSIDE;

ABDOMINAL CANCER; ARTICLE; CANCER RADIOTHERAPY; CLINICAL FEATURE; COMA; CONFUSION; CREATININE CLEARANCE; DEATH; DISEASE COURSE; DYSPNEA; EDEMA; FATIGUE; HEADACHE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY INJURY; LATENT PERIOD; MATHEMATICAL MODEL; NAUSEA; ORGAN SIZE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION INJURY; SIDE EFFECT; VALIDATION PROCESS; VOMITING; WEIGHT GAIN; WHOLE BODY RADIATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FORECASTING; HUMANS; KIDNEY; MODELS, ANIMAL; RADIATION INJURIES; RADIATION TOLERANCE; WHOLE-BODY IRRADIATION;

EID: 76449087155     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.089     Document Type: Article

References (46)

1. Cruz D.N., Perazella M.A., and Mahnensmith R.L. Bone marrow transplant nephropathy: A case report and review of the literature. J Am Soc Nephrol 8 (1997) 166-173
2. Rubin P., and Casarett G. Clinical Radiation Pathology Vols. 1 and 2 (1968), WB Saunders, Philadelphia
3. Verheij M., Dewit L.G., Valdes Olmos R.A., et al. Evidence for a renovascular component in hypertensive patients with late radiation nephropathy. Int J Radiat Oncol Biol Phys 30 (1994) 677-683
4. Cohen E.P., and Robbins M.E. Radiation nephropathy. Semin Nephrol 23 (2003) 486-499
5. Thompson P.L., Mackay I.R., Robson G.S., et al. Late radiation nephritis after gastric x-irradiation for peptic ulcer. Q J Med 40 (1971) 145-157
6. Ahmad N.R., Huq M.S., and Corn B.W. Respiration-induced motion of the kidneys in whole abdominal radiotherapy: Implications for treatment planning and late toxicity. Radiother Oncol 42 (1997) 87-90
7. Reiff J.E., Werner-Wasik M., Valicenti R.K., et al. Changes in the size and location of kidneys from the supine to standing positions and the implications for block placement during total body irradiation. Int J Radiat Oncol Biol Phys 45 (1999) 447-449
8. Cheng J., Schultheiss T., and Wong J. Impact of drug therapy, radiation dose and dose rate on renal toxicity following bone marrow transplantation. Int J Radiat Oncol Biol Phys 71 (2008) 436-443
9. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
10. Cassady J.R. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 31 (1995) 1249-1256
11. Schneider D.P., Marti H.P., Von Briel C., et al. Long-term evolution of renal function in patients with ovarian cancer after whole abdominal irradiation with or without preceding cisplatin. Ann Oncol 10 (1999) 677-683
12. McKiernan J., Simmons R., Katz J., et al. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59 (2002) 816-820
13. Welz S., Hehr T., Kollmannsberger C., et al. Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer. Int J Radiat Oncol Biol Phys 69 (2007) 1429-1435
14. Willett C.G., Tepper J.E., Orlow E.L., et al. Renal complications secondary to radiation treatment of upper abdominal malignancies. Int J Radiat Oncol Biol Phys 12 (1986) 1601-1604
15. Jansen E.P., Saunders M.P., Boot H., et al. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys 67 (2007) 781-785
16. Kost S., Dorr W., Keinert K., et al. Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy. Int J Radiat Biol 78 (2002) 695-702
17. Peschel R.E., Chen M., and Seashore J. The treatment of massive hepatomegaly in stage IV-S neuroblastoma. Int J Radiat Oncol Biol Phys 7 (1981) 549-553
18. Esiashvili N., Chiang K.Y., Hasselle M.D., Bryant C., Riffenburgh R.H., and Paulino A.C. Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol 90 2 (2009 Feb) 242-246
19. Mitus A., Tefft M., and Fellers F.X. Long-term follow-up of renal functions of 108 children who underwent nephrectomy for malignant disease. Pediatrics 44 (1969) 912-921
20. Paulino A.C., Wilimas J., Marina N., et al. Local control in synchronous bilateral Wilms tumor. Int J Radiat Oncol Biol Phys 36 (1996) 541-548
21. Ritchey M.L., Green D.M., Thomas P.R., et al. Renal failure in Wilms tumor patients: A report from the National Wilms Tumor Study Group. Med Pediatr Oncol 26 (1996) 75-80
22. Dewit L., Verheij M., Valdes Olmos R.A., et al. Compensatory renal response after unilateral partial and whole volume high-dose irradiation of the human kidney. Eur J Cancer 29A (1993) 2239-2243
23. Kunkler P.B., Farr R.W., and Luxton R.W. The Limit of Renal Tolerance to X Rays. Br J Radiol XXV (1952) 190-201
24. Avioli L.V., Lazor M.Z., Cotlove E., et al. Early effects of radiation on renal function in man. American Journal of Medicine 34 (1963) 329-337
25. Keane W.F., Crosson J.T., Staley N.A., et al. Radiation-induced renal disease. A clinicopathologic study. Am J Med 60 (1976) 127-137
26. Churchill D.N., Hong K., and Gault M.H. Radiation nephritis following combined abdominal radiation and chemotherapy (bleomycin vinblastine). Cancer 47 (1978) 2162-2164
27. Irwin C., Fyles A., Wong C.S., et al. Late renal function following whole abdominal irradiation. Radiotherapy & Oncology 38 (1996) 257-261
28. Donaldson S.S., Moskowitz P.S., Canty E.L., et al. Combination radiation-adriamycin therapy: Renoprival growth, functional and structural effects in the immature mouse. Int J Radiat Oncol Biol Phys 6 (1980) 851-859
29. Moulder J.E., Fish B.L., and Cohen E.P. Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists. Curr Pharm Des 13 (2007) 1317-1325
30. Cohen E.P., Fish B.L., Sharma M., et al. Role of the angiotensin II type-2 receptor in radiation nephropathy. Transl Res 150 (2007) 106-115
31. Verheij M., Stewart F.A., Oussoren Y., et al. Amelioration of radiation nephropathy by acetylsalicylic acid. Int J Radiat Biol 67 (1995) 587-596
32. Cohen E.P., Hussain S., and Moulder J.E. Successful treatment of radiation nephropathy with angiotensin II blockade. Int J Radiat Oncol Biol Phys 55 (2003) 190-193
33. Cohen E.P., Irving A.A., Drobyski W.R., et al. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: A randomized controlled trial. Int J Radiat Oncol Biol Phys 70 (2008) 1546-1551
34. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
35. Nevinny-Stickel M., Poljanc K., Forthuber B.C., et al. Optimized conformal paraaortic lymph node irradiation is not associated with enhanced renal toxicity. Strahl Onkol 183 (2007) 385-391
36. Svedman C., Sandstrom P., Pisa P., et al. A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 45 (2006) 870-875
37. Wersall P.J., Blomgren H., Lax I., et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 77 (2005) 88-95
38. Beitler J.J., Makara D., Silverman P., et al. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol 27 (2004) 646-648
39. Teh B., Bloch C., Galli-Guevara M., et al. The treatment of primary and metastatic renal cell carcinoma (RCC) with image guided stereotactic body radiation therapy (SBRT). Biomed Imaging Intev J 3 (2007) 1-9
40. LeBourgeois J., Meignan M., Parmentier C., et al. Renal consequences of irradiation of the spleen in lymphoma patients. Abritish Journal of Radiology 52 (1979) 56-60
41. Birkhead B.M., Dobbs C.E., Beard M.F., et al. Assessment of renal function following irradiation of the intact spleen for Hodgkin disease. Radiology 130 (1979) 473-475
42. Kim T.H., Freeman C.R., and Webster J.H. The significance of unilateral radiation nephropathy. Int J Radiat Oncol Biol Phys 6 (1980) 1567-1571
43. Kim T.H., Somerville P.J., and Freeman C.R. Unilateral radiation nephropathy--the long-term significance. Int J Radiat Oncol Biol Phys 10 (1984) 2053-2059
44. Flentje M., Hensley F., Gademann G., et al. Renal tolerance to nonhomogenous irradiation: comparison of observed effects to predictions of normal tissue complication probability from different biophysical models. Int J Radiat Oncol Biol Phys 27 (1993) 25-30
45. Svedman C., Karlsson K., Rutkowska E., Sandstrom P., Blomgren H., Lax I., Wersall P., et al. Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney. Acta Oncologica 47 8 (2008) 1578-1583
46. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100